GDNF-CPP fusion protein (Guangzhou KaiNuo Biological Technology)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameGDNF-CPP fusion protein (Guangzhou KaiNuo Biological Technology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlial cell line-derived neurotrophic factor receptors agonistsNeuroprotectants
TargetsGlial cell line-derived neurotrophic factor receptors
Therapy Area/IndicationsTrauma, Nervous SystemCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGuangzhou KaiNuo Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangzhou KaiNuo Biological Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsTrauma, Nervous SystemCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A